Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir □) in advanced HIV infection
Objectives: To assess the efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine; GPO-vir □ in advanced HIV infection. Material and Method: Open-label combined prospective and retrospective study involving 102 HIV infected patients with baseline CD4cell count &...
Saved in:
Main Authors: | Aneley Getahun, Somsit Tansuphasawadikul, Varunee Desakorn, Jittima Dhitavat, Punnee Pitisuttithum |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/23540 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: A 3-year follow-up
by: Varunee Desakorn, et al.
Published: (2018) -
The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients
by: Ei E. Tin, et al.
Published: (2018) -
Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR□) in Thai HIV-infected patients
by: Sasisopin Kiertiburanakul, et al.
Published: (2018) -
Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients
by: Weerawat Manosuthi, et al.
Published: (2018) -
Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR®) for the treatment of advanced HIV-infected patients: A 24-week study
by: Thanomsak Anekthananon, et al.
Published: (2018)